A comprehensive view of Pharmacyclics Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

J&J and Pharmacyclics receive FDA approval for oral suspension of IMBRUVICA to treat chronic lymphocytic leukemia /small lymphocytic lymphoma, Waldenström's macroglobulinemia, and chronic graft versus host disease
Published: February 26, 2024 by Janssen Pharmaceutical Companies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count